The prevalence of the BRAF V600E mutation is high among patients diagnosed with MM, with a frequency ranging from 2% to 4% in newly diagnosed cases and rising to approximately 8% in patients with relapsed/refractory disease or extramedullary involvement [97]. Here, BRAF is linked to Miyoshi myopathy.